Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma of the Urinary Bladder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01622660
What this trial is testing

Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Chemotherapy

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT02009332
What this trial is testing

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Aadi Bioscience, Inc. 21
Early research (Phase 1)Study completedNCT00003133
What this trial is testing

Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00066352
What this trial is testing

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT00006026
What this trial is testing

Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 21
Testing effectiveness (Phase 2)Study completedNCT02662309
What this trial is testing

Preoperative MPDL3280A in Transitional Cell Carcinoma of the Bladder

Who this might be right for
Bladder Cancer
Queen Mary University of London 96
Testing effectiveness (Phase 2)Ended earlyNCT02560038
What this trial is testing

Trial of Paclitaxel Plus Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Urinary Bladder Neoplasms
The University of Texas Health Science Center, Houston 3
Not applicableStudy completedNCT05742867
What this trial is testing

Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Neoplasms
Bristol-Myers Squibb 115
Testing effectiveness (Phase 2)Study completedNCT00014144
What this trial is testing

S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 31
Large-scale testing (Phase 3)Study completedNCT00445601
What this trial is testing

S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 406
Not applicableNot Yet RecruitingNCT05335512
What this trial is testing

Intravesical BCG: is the Urinary Bladder Ready to Receive it

Who this might be right for
Non-Invasive Bladder Urothelial Carcinoma
Tata Memorial Centre 100
Not applicableUnknownNCT04740866
What this trial is testing

Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer

Who this might be right for
High-Risk CancerUrothelial Carcinoma Bladder
Cairo University 100
Large-scale testing (Phase 3)Looking for participantsNCT07566156
What this trial is testing

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Who this might be right for
Urothelial CancerUrinary Bladder Neoplasms
Astellas Pharma Global Development, Inc. 390
Large-scale testing (Phase 3)Looking for participantsNCT07419295
What this trial is testing

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 590
Post-approval studies (Phase 4)UnknownNCT05488353
What this trial is testing

A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 48
Large-scale testing (Phase 3)Looking for participantsNCT06537154
What this trial is testing

NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Peter Black 688
Not applicableLooking for participantsNCT07225205
What this trial is testing

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy

Who this might be right for
Bladder CancerMuscle Invasive Bladder Cancer (MIBC)Muscle Invasive Bladder Cancer Urothelial Carcinoma+1 more
Johns Hopkins University 130
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00777491
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Who this might be right for
Bladder Cancer
Radiation Therapy Oncology Group 70
Large-scale testing (Phase 3)Study completedNCT00002490
What this trial is testing

Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Medical Research Council
Next Page